Immunotherapies targeting neoantigens are effective in PD-1 blockade-resistant tumors. Sun C, Nagaoka K, Kobayashi Y, Maejima K, et al. Int J Cancer 2023;152:1463-1475.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun C, Nagaoka K, Kobayashi Y, Maejima K, et al. Immunotherapies targeting neoantigens are effective in PD-1 blockade-resistant tumors. Int J Cancer 2023;152:1463-1475.
PMID: 36451303